Status:

COMPLETED

Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood

Lead Sponsor:

Ascensia Diabetes Care

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The purpose of the study was to evaluate the performance of the meter system in the hands of subjects and healthcare professionals (HCPs). It also evaluated the product user guides in the hands of unt...

Detailed Description

The study evaluated the performance of the blood glucose meter system (BGMS) compared to a laboratory glucose method. Subjects and healthcare professionals tested subject capillary blood and healthcar...

Eligibility Criteria

Inclusion

  • Have type 1 or type 2 diabetes
  • Be \> 18, \< 76 year of age at time of consent, with approximately 50% (+10%)being less than 55 years of age
  • Be willing to complete all study procedures
  • Be routinely testing their blood sugar at home (at least once per day)
  • Be able to speak, read, and understand English and understand the Informed Consent document
  • Be able to read the labeling instructions

Exclusion

  • Minors \< 18 years of age and adults \> 75 years of age
  • Pregnancy
  • Physical (dexterity), visual, or neurological impairments that would make the person unable to perform testing with the BGMS
  • Disorders in the fingertip lancing areas
  • Acute or chronic infections, particularly skin infections
  • Infection with a blood borne pathogen
  • Taking prescription anti-coagulants or having clotting problems that may prolong bleeding. Taking aspirin daily (81 mg or 325 mg) is not reason for exclusion
  • Hemophilia or any other bleeding disorder
  • Having a condition which, in the opinion of the Principal Investigator or designee, would put the person at risk or seriously compromise the integrity of the study
  • Working for a competitive medical device company

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT00797563

Start Date

November 1 2008

End Date

November 1 2008

Last Update

February 29 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Consumer Product Testing Co., Inc.

Fairfield, New Jersey, United States, 07004

Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood | DecenTrialz